APGE
Apogee Therapeutics, Inc.
135.10$
+0.0%
vs. previous close
Closing price · As of: Sep 3, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | – | – | +650.3% | |
| – | – | – | – | |
| – | +146.3% | +145.3% | +27.9% | |
| – | +735.7% | +99.4% | +44.6% | |
| – | +202.7% | +133.2% | +31.0% | |
| – | – | – | – | |
| – | -100.0% | – | – | |
| – | – | – | – | |
| – | – | – | +1,444.4% | |
| – | – | – | – | |
| – | – | – | – |
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.